|
|
Article: FDA Advisory Panel Overwhelmingly Supports WellPoint Petition to Switch Claritin, Allegra and Zyrtec From Prescription to Over-the-Counter Status.
- Article from:
- Business Wire
- Article date:
- May 11, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
GAITHERSBURG, Md.--(BW HealthWire)--May 11, 2001
Urges FDA and Manufacturers to Make the Drugs Available Quickly
WellPoint (NYSE:WLP) said today's recommendation by the Nonprescription Drugs and Pulmonary and Allergy Drugs Advisory Committees of the U.S. Food and Drug Administration (FDA) that the agency switch the allergy drugs Claritin, Allegra and Zyrtec from prescription to over-the-counter (OTC) status clearly supports the Company's continuing efforts to empower the 40 million Americans who suffer from allergies.
Robert Seidman, PharmD, M.P.H., chief pharmacy officer, WellPoint, said, "We ...